Notice of extraordinary general meeting of Nuevolution AB (publ)
At the request of Amgen Inc., which after completion of the public takeover offer to the shareholders of Nuevolution AB (publ), reg.no. 559026-4304, with its registered office in Stockholm, (“Nuevolution” or the “Company”) holds 97.6 per cent of the total number of shares and votes in Nuevolution, the shareholders of Nuevolution, are hereby summoned to the extraordinary general meeting on Thursday 1 August 2019 at 13:00 CEST at Advokatfirman Vinge’s offices, Stureplan 8, Stockholm. Right to attend the general meeting Shareholders who wish to attend the general meeting must be